21 CFR part 11 Compliance - electronic records & electronic signatures

MessageThis Webinar is over
Date May 6, 2019
Time 12:30 PM PT | 03:30 PM ET
Cost 179.00
Online
Overview

This Webinar will explain what 21 CFR Part 11 is, why it is important to FDA regulated companies and how conformance to Part 11 differs from just having good IT security. Procedures for controlling electronic signatures and electronic records will be explained. FDA regulated companies want to transition to electronic records for economy and efficiency. FDA, because of its concern for patient safety, wants to prevent electronic records from being compromised with possible resulting harm to the patient. FDA has set up regulations that address both data security and patient safety. We will show how 21 CFR part 11 considers both. The confusion over the original FDA regulation and its subsequent "selective enforcement" will be explained

Why should you attend this webinar?

Companies want to transition to electronic records but are afraid of compromising their quality system and receiving 483's at their next inspection. Part of this fear originates from confusion. FDA originally published a rather severe 21 CFR Part 11. After industry complaints the FDA acknowledged that the regulation, as written, would result in nobody attempting to convert to electronic records. But, instead of rewriting the regulation, FDA said it would "selectively enforce" sections of the regulation. This webinar will explain what all this means.

Areas Covered in the Session:
 
  • Company certification
  • Records covered
  • Audit trails
  • Open /closed system access rules
  • Electronic signatures
  • Training requirements

Who can Benefit:
 
  • Engineering personnel
  • Regulatory personnel
  • IT
  • Management

Speaker Profile:

Edwin Waldbusser is Keynote Speaker at ComplianceKey. He is retired from industry after 30 years in management of development of medical device products and development of company Quality Systems. Products included IVD devices, kidney dialysis systems and inhalation devices. QS experience includes design control, risk analysis, CAPA, software validation, supplier qualification/ control and manufacturing.

Register: https://www.compliancekey.us/webinarDetails?industryId=3&webinarid=1429&speakerid=48

Contact Info:

Compliance Key

Email: support@compliancekey.us

Visit: https://www.compliancekey.us/upcoming-webinars

Phone: 717-208-8666

 


comments powered by Disqus
Create your own event
Turn your passion into a business.
Join our mailing list